Advertisement

TRLV

Trulieve Cannabis Corp.

Healthcare · USD

Set alert

Price alert · TRLV

All alert types
10.28 USD -0.32 -3.02%
As of Oct 30, 2026 Extended hours 10.30 +0.19%
Bid
10.20 × 200
Ask
10.34 × 200
9.91 Day range 10.48
4.76 52-week range 13.00
YTD
+18.30%
1 year
+48.34%
Open
10.46
Prev close
10.60
Mkt cap
1.98B
Vol
1.41M
Avg vol
1.69M
EPS
-2.43
P/E
0.00
Div yield
0.00%
More statistics
Low
9.91
High
10.48
Forward P/E
18.25
Beta
1.80
Short ratio
2.91
Inst. own
24.66%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
11.19
200-d avg
8.81
1y target
18.18

5D chart

Chart tools
Interval
TRLV five-day price chart9.9010.210.410.710.9Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
1.98B
Enterprise value
2.29B
Trailing P/E
0.00
Forward P/E
18.25
PEG ratio
0.00
Price / sales
1.74
Price / book
2.58
EPS (TTM)
-2.43
Beta
1.80
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-41.55%
Revenue (TTM)
1.14B
Revenue growth
-10.30%
Free cash flow
232.04M
Total cash
325.42M
Total debt
577.87M
Return on equity
-47.65%
Shares outstanding
170.16M
Short % of float
4.36%
50-day average
11.19
200-day average
8.81

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 18.18 +76.8% upside
Target (low)
15.00
Target (mean)
18.18
Target (high)
21.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 0.07.

Earnings history

Financials — quick view

All financials
TRLV Revenue — quarterly 270.95M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TRLV Net income — quarterly -405.98M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TRLV EPS — quarterly -2.10
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

TRLV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20260.0925———
Aug 6, 2026Jun 30, 20260.06-2.11-2.17-3,616.67%
May 7, 2026Mar 31, 2026-0.014120.01+0.02+170.82%
Feb 26, 2026Dec 31, 2025-0.07427-0.22-0.15-196.22%
Nov 5, 2025Sep 30, 2025-0.08458-0.14-0.06-65.52%
Aug 6, 2025Jun 30, 2025-0.06038-0.07-0.01-15.93%

Upgrades / downgrades

TRLV analyst upgrades and downgrades
DateFirmActionFromTo
Oct 23, 2026Cantor FitzgeraldreitOverweightOverweight
Aug 7, 2026Cantor FitzgeraldreitOverweightOverweight
Jul 20, 2026Cantor Fitzgeraldinit—Overweight

About Trulieve Cannabis Corp.

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
trulieve.com

News

Your note

Sign in to keep a note on TRLV — it syncs with the Stock Master app.

Insider holders

TRLV insider holders
InsiderRelationLatest transactionDateShares held
Hersey (Christine Ann)Senior Officer of IssuerOpening Balance-Initial SEDI ReportJan 13, 202633,874
Jhala (Nilyum)Senior Officer of IssuerExercise of rightsNov 30, 202572,358
Landrum (Kyle Finn)Senior Officer of IssuerExercise of rightsNov 30, 202588,380
Malivuk (Joy)Senior Officer of IssuerExercise of rightsNov 30, 202540,033
Morey (Timothy J.)Senior Officer of IssuerExercise of rightsNov 30, 202557,354
Pernell (Jason Barry)Senior Officer of IssuerExercise of rightsNov 30, 2025411,399

Institution ownership

TRLV institution ownership
Holder% heldSharesValueReported
AdvisorShares Investments, LLC6.25%10,641,152109.39MJun 29, 2026
Nomura Holdings Inc.2.98%5,065,84952.08MJun 29, 2026
Cantor Fitzgerald, L.P.2.20%3,750,00038.55MJun 29, 2026
Marex Group Ltd.1.91%3,250,00033.41MJun 29, 2026
ING Groep N.V.1.57%2,665,00027.40MJun 29, 2026
Oakmont Corp0.89%1,506,51115.49MJun 29, 2026

Fund ownership

TRLV fund ownership
Holder% heldSharesValueReported
AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF15.16%25,789,194265.11MSep 29, 2026
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF0.28%471,9074.85MSep 29, 2026
iShares Trust-iShares Core S&P Total U.S. Stock Market ETF0.13%223,9162.30MSep 29, 2026
Northern Funds-SMALL CAP VALUE FUND0.03%55,312568.61KJun 29, 2026
TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund0.02%39,800409.14KJun 29, 2026
Advertisement